DEVICE CATEGORY · NBC
Test, Natriuretic Peptide
FDA classification: Clinical Chemistry. Device class 2.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Access BNP IIK262597 | BECKMAN COULTER, INC. | 510(k) clearance | Oct 20, 2026 | FDA |
Access NT-proBNPK262109 | BECKMAN COULTER, INC. | 510(k) clearance | Sep 21, 2026 | FDA |
Source information
Follow the FDA links to view the original records.

